Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
City Trees is a Nevada-based cannabis cultivation and production company specializing in high-purity concentrates, vapes, and tinctures. Operating as a subsidiary of TILT Holdings, the company utilizes advanced ethanol and CO2 extraction technologies to formulate a diverse portfolio of cannabinoid-based wellness products. City Trees is particularly recognized for its proprietary terpene blends and its commitment to environmental sustainability through its "1-for-1" initiative, which plants a tree for every product sold. Their product line is designed for both medicinal and adult-use markets, focusing on consistent delivery of therapeutic compounds like THC and CBD. The company maintains a strong presence in the Nevada and Massachusetts markets, providing lab-tested, high-quality extracts to retail dispensaries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on City Trees.